Fysicon B.V. has been acquired by Canon Medical Systems
Canon Medical Systems Corporation, a Japan-based developer of medical diagnostic imaging systems and medical solutions, has acquired Fysicon B.V., a developer of healthcare information systems in the Netherlands, for an undisclosed consideration.
Fysicon is a developer and assembler of innovative medical software and hardware for hospitals, clinics and research institutes. Since its foundation in 1996 and with unique advanced technologies and clinical evidence, Fysicon has developed and manufactured product families such as cardiovascular monitoring systems. Fysicon's CEO Linda Elberse, said: "Now we are ready to take our business to the next level, and we truly appreciate the Dutch team's role in helping to make it happen."
Canon Medical Systems Corporation develops medical diagnostic imaging systems and medical solutions. It offers angiography, computed tomography, magnetic resonance, ultrasound, X-ray, nuclear medicine, healthcare imaging informatics systems and RF amplifier components. The company was founded in 1930 and is headquartered in Otawara-shi, Japan, with subsidiaries in Japan, North America, South America, Europe, Africa, the Mid-East, Asia, and Oceania.
Oaklins' healthcare team in the Netherlands advised the selling shareholder throughout the process.
Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more